Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the identification of those patients with the worst prognosis is mandatory. Liver biopsy is still the diagnostic gold standard, even if it is associated to a significant rate of complications; moreover, the interpretation of histological samples is not always univocal. Several non-invasive alternative scores have been proposed for the diagnostic approach to non-alcoholic fatty liver disease. This article evaluates the performance of the currently available non-invasive diagnostic strategies. The authors also suggest a potential diagnostic algorithm, with two or more non-invasive techniques, to increase the overall accuracy for identifying patien...
International audienceNAFLD is a frequent disease that affects 25% of the worldwide population. Ther...
Background Non-alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of clinical conditi...
Hepatic steatosis is the buildup of lipids within hepatocytes. It is the simplest stage in nonalcoho...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
SummaryNon-alcoholic fatty liver disease (NAFLD) affects one in every three subjects in the occident...
Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chro...
NAFLD (Non-Alcoholic Fatty Liver Disease) is an increasingly significant public health issue, regard...
The global prevalence of nonalcoholic fatty liver disease (NAFLD) or metabolic associated fatty live...
Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of chronic liver di...
The diagnostic phenotype of nonalcoholic fatty liver disease (NAFLD)—in particular, the most signifi...
Non-alcoholic fatty liver disease (NAFLD) has become the most common liver alteration worldwide. It ...
Nonalcoholic fatty liver disease (NAFLD) affects about 20%-30% of the general population, and its cl...
International audienceNAFLD is a frequent disease that affects 25% of the worldwide population. Ther...
Background Non-alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of clinical conditi...
Hepatic steatosis is the buildup of lipids within hepatocytes. It is the simplest stage in nonalcoho...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
SummaryNon-alcoholic fatty liver disease (NAFLD) affects one in every three subjects in the occident...
Introduction. Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common chro...
NAFLD (Non-Alcoholic Fatty Liver Disease) is an increasingly significant public health issue, regard...
The global prevalence of nonalcoholic fatty liver disease (NAFLD) or metabolic associated fatty live...
Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of chronic liver di...
The diagnostic phenotype of nonalcoholic fatty liver disease (NAFLD)—in particular, the most signifi...
Non-alcoholic fatty liver disease (NAFLD) has become the most common liver alteration worldwide. It ...
Nonalcoholic fatty liver disease (NAFLD) affects about 20%-30% of the general population, and its cl...
International audienceNAFLD is a frequent disease that affects 25% of the worldwide population. Ther...
Background Non-alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of clinical conditi...
Hepatic steatosis is the buildup of lipids within hepatocytes. It is the simplest stage in nonalcoho...